Our Blog - Tag: Dangerous Pharmaceuticals

Medical experts in the U.S. and around the world are beginning to review the safety of newer forms of oral contraceptive pills. The safety of these potentially dangerous pharmaceuticals has been debated due to the risk of blood clots and strokes they pose. Some studies have shown that newer, third- and fourth-generation birth control pills…

Drugmaker Boehringer Ingelheim has started to inform physicians that its drug Pradaxa (dabigatran) is not safe for patients with mechanical heart valves. The German pharmaceutical giant says that its oral anticoagulant should not be given to patients with mechanical heart valves because it increases their risk of strokes. The U.S. Food and Drug Administration (FDA)…

A woman recently filed a pharmaceutical liability lawsuit against Abbott Laboratories alleging that its popular arthritis drug Humira caused her to develop cancer. The woman received Humira injections for about two years before she developed B-cell non-Hodgkin’s follicular lymphoma. The cancer is now in remission, but she will have to undergo a lifetime of treatment…

A recently released CDC study indicates that a third of U.S. prescription painkiller overdoses are caused by methadone, despite the drug only accounting for two percent of all painkiller prescriptions. The prevalence of methadone overdoses appears to be linked to medical negligence, as physicians often inappropriately prescribe methadone for patients to use on a long-term…

Pharmaceutical giant GlaxoSmithKline was recently slapped with a $3 billion fine for illegally marketing a variety of drugs for unapproved, off-label uses. Authorities brought criminal and civil fines against GSK for its marketing of Paxil, Webutrin, Avandia, and other drugs, which may have exposed many patients to unnecessary personal injuries. Authorities specifically accuse GSK of…

Pharmaceutical giant Johnson & Johnson may have to pay over $1.8 billion to settle claims related to its marketing of its blockbuster antipsychotic drug Risperdal. The drug was once Johnson & Johnson’s best-selling drug, generating over $24 billion in 2003. Risperdal was approved by the Food and Drug Administration to treat psychotic disorders, but the…